Answers are grounded in this paper and cite their sources.
The technological progress in artificial intelligence (AI) has massively accelerated since 2022, with far-reaching implications for oncology and cancer research. Large language models (LLMs) now perform at human-level competency in text processing. Notably, both text and image processing networks are increasingly based on transformer neural networks. This convergence enables the development of multimodal AI models that take diverse types of data as an input simultaneously, marking a qualitative shift from specialized niche models which were prevalent in the 2010s. This editorial summarizes these developments, which are expected to impact precision oncology in the coming years.
No takes yet. Share an insight, caveat, or question.
Truhn et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: